CBU
TXG icon

CIBC Bancorp USA’s 10x Genomics TXG Stock Holding History

CIBC Bancorp USA’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$134K Buy
+11,434
New +$149K ﹤0.01% 1324

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIBC Bancorp USA's TXG Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in 10x Genomics (TXG) in Q3 2025: 11,434 shares worth $134K. The stake represents ﹤0.01% of the portfolio and ranks #1324 among its holdings.

317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • CIBC Bancorp USA held 11,434 shares of 10x Genomics worth $134K as of Q3 2025.
  • 10x Genomics was a new CIBC Bancorp USA position in Q3 2025.
  • 10x Genomics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1324 holding.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.